Publication | Open Access
Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
792
Citations
16
References
1993
Year
This regimen appears to prolong survival in patients with advanced gastric cancer, and the reduction of the methotrexate dose does not seem to compromise its efficacy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1